Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Novel treatment of cutaneous T cell lymphoma: Targeting TNFR2, an oncogene and marker of potent Tregs, with anti-TNFR2 antibodies Torrey, H., Defusco, A., Baum, D., Rhabar, Z., Khodadoust, M., Kim, Y. H., Faustman, D. L. AMER ASSOC CANCER RESEARCH. 2018
View details for DOI 10.1158/2326-6074.TUMIMM17-B18
View details for Web of Science ID 000456801700070